{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:26:38Z","timestamp":1783427198674,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"DOI":"10.7759\/cureus.100881","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:53:36Z","timestamp":1767682416000},"source":"Crossref","is-referenced-by-count":1,"title":["Effect of Human Papillomavirus (HPV) Vaccine on Male Genital Disease: A Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.7759","author":[{"given":"Praveen Kumar","family":"Tagore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnesh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Sexually transmitted infections (STIs). (2021). Accessed. October 24, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis)."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel C","year":"2020","unstructured":"de Martel C, Georges D, Bray F, et al.. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020, 8:180-90. 10.1016\/S2214-109X(19)30488-7","journal-title":"Lancet Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.03.003","article-title":"Epidemiology and natural history of penile cancer","volume":"76","author":"Pow-Sang MR","year":"2010","unstructured":"Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V. Epidemiology and natural history of penile cancer. Urology. 2010, 76:S2-6. 10.1016\/j.urology.2010.03.003","journal-title":"Urology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.09.003","article-title":"Epidemiology of oral human papillomavirus infection","volume":"50","author":"Chung CH","year":"2014","unstructured":"Chung CH, Bagheri A, D'Souza G. Epidemiology of oral human papillomavirus infection. Oral Oncol. 2014, 50:364-9. 10.1016\/j.oraloncology.2013.09.003","journal-title":"Oral Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis","volume":"11","author":"Bruni L","year":"2023","unstructured":"Bruni L, Albero G, Rowley J, et al.. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health. 2023, 11:e1345-62. 10.1016\/S2214-109X(23)00305-4","journal-title":"Lancet Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164215","article-title":"The impact of the human papillomavirus vaccine on high-grade cervical lesions in urban and rural areas: an age-period-cohort analysis","volume":"13","author":"Shing JZ","year":"2021","unstructured":"Shing JZ, Beeghly-Fadiel A, Griffin MR, et al.. The impact of the human papillomavirus vaccine on high-grade cervical lesions in urban and rural areas: an age-period-cohort analysis. Cancers (Basel). 2021, 13:4215. 10.3390\/cancers13164215","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.01.026","article-title":"Epidemiology and pathology of HPV disease in males","volume":"117","author":"Giuliano AR","year":"2010","unstructured":"Giuliano AR, Anic G, Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol. 2010, 117:S15-9. 10.1016\/j.ygyno.2010.01.026","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1098-3","article-title":"Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review","volume":"16","author":"Harder T","year":"2018","unstructured":"Harder T, Wichmann O, Klug SJ, van der Sande MA, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018, 16:110. 10.1186\/s12916-018-1098-3","journal-title":"BMC Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16692","article-title":"Efficacy of human papillomavirus vaccines in the prevention of male genital diseases: a systematic review","volume":"135","author":"Kardoust Parizi M","year":"2025","unstructured":"Kardoust Parizi M, Singla N, Matsukawa A, et al.. Efficacy of human papillomavirus vaccines in the prevention of male genital diseases: a systematic review. BJU Int. 2025, 135:902-7. 10.1111\/bju.16692","journal-title":"BJU Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28697","article-title":"The impact of human papilloma virus on human reproductive health and the effect on male infertility: an updated review","volume":"95","author":"Das S","year":"2023","unstructured":"Das S, Doss C GP, Fletcher J, Kannangai R, Abraham P, Ramanathan G. The impact of human papilloma virus on human reproductive health and the effect on male infertility: an updated review. J Med Virol. 2023, 95:e28697. 10.1002\/jmv.28697","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz J","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F, et al.. European Association of Urology guidelines on urological infections: summary of the 2024 guidelines. Eur Urol. 2024, 86:27-41. 10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2019.100037","article-title":"Educating healthcare providers to increase human papillomavirus (HPV) vaccination rates: a qualitative systematic review","volume":"3","author":"Leung SO","year":"2019","unstructured":"Leung SO, Akinwunmi B, Elias KM, Feldman S. Educating healthcare providers to increase human papillomavirus (HPV) vaccination rates: a qualitative systematic review. Vaccine X. 2019, 3:100037. 10.1016\/j.jvacx.2019.100037","journal-title":"Vaccine X"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano AR","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, et al.. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011, 364:401-11. 10.1056\/NEJMoa0909537","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2552061","article-title":"Addressing male HPV vaccination in China: a narrative review of challenges and opportunities","volume":"21","author":"Wong LP","year":"2025","unstructured":"Wong LP, Chen X, Huang Z, Zimet G, Zhao Q, Lin Y, Hu Z. Addressing male HPV vaccination in China: a narrative review of challenges and opportunities. Hum Vaccin Immunother. 2025, 21:2552061. 10.1080\/21645515.2025.2552061","journal-title":"Hum Vaccin Immunother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164080","article-title":"Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications","volume":"15","author":"Ndon S","year":"2023","unstructured":"Ndon S, Singh A, Ha PK, Aswani J, Chan JY, Xu MJ. Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications. Cancers (Basel). 2023, 15:4080. 10.3390\/cancers15164080","journal-title":"Cancers (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker TH","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, et al.. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023, 21:494-506. 10.11124\/JBIES-22-00430","journal-title":"JBI Evid Synth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.01.069","article-title":"Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: a randomized, phase 3, placebo-controlled study","volume":"37","author":"Mikamo H","year":"2019","unstructured":"Mikamo H, Yamagishi Y, Murata S, et al.. Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: a randomized, phase 3, placebo-controlled study. Vaccine. 2019, 37:1651-8. 10.1016\/j.vaccine.2019.01.069","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12670","article-title":"Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study","volume":"11","author":"Coskuner ER","year":"2014","unstructured":"Coskuner ER, Ozkan TA, Karakose A, Dillioglugil O, Cevik I. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study. J Sex Med. 2014, 11:2785-91. 10.1111\/jsm.12670","journal-title":"J Sex Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00327-3","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Goldstone SE","year":"2022","unstructured":"Goldstone SE, Giuliano AR, Palefsky JM, et al.. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022, 22:413-25. 10.1016\/S1473-3099(21)00327-3","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11061083","article-title":"Impact of human papillomavirus vaccination on male disease: a systematic review","volume":"11","author":"Rosado C","year":"2023","unstructured":"Rosado C, Fernandes \u00c2R, Rodrigues AG, Lisboa C. Impact of human papillomavirus vaccination on male disease: a systematic review. Vaccines (Basel). 2023, 11:1083. 10.3390\/vaccines11061083","journal-title":"Vaccines (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.080","article-title":"Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain","volume":"35","author":"Navarro-Illana E","year":"2017","unstructured":"Navarro-Illana E, L\u00f3pez-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Vaccine. 2017, 35:3342-6. 10.1016\/j.vaccine.2017.04.080","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29137","article-title":"HPV vaccination in boys and men","volume":"10","author":"Stanley M","year":"2014","unstructured":"Stanley M. HPV vaccination in boys and men. Hum Vaccin Immunother. 2014, 10:2109-11. 10.4161\/hv.29137","journal-title":"Hum Vaccin Immunother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434965-effect-of-human-papillomavirus-hpv-vaccine-on-male-genital-disease-a-meta-analysis-of-randomised-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:53:37Z","timestamp":1767682417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434965-effect-of-human-papillomavirus-hpv-vaccine-on-male-genital-disease-a-meta-analysis-of-randomised-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.100881","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}